923 research outputs found

    A note on q-Bernoulli numbers and polynomials

    Full text link
    By using p-adic q-integrals, we study the q-Bernoulli numbers and polynomials of higher order.Comment: 8 page

    A Note on the -Euler Numbers and Polynomials with Weak Weight

    Get PDF
    We construct a new type of -Euler numbers and polynomials with weak weight : (),, (),(), respectively. Some interesting results and relationships are obtained. Also, we observe the behavior of roots of the -Euler numbers (), and polynomials (),() with weak weight . By means of numerical experiments, we demonstrate a remarkably regular structure of the complex roots of -Euler polynomials (), with weak weight

    Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D(3 )receptor

    Get PDF
    BACKGROUND: Our aim was to determine if pramipexole, a D(3 )preferring agonist, effectively reduced dopamine neuron and fiber loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model when given at intraperitoneal doses corresponding to clinical doses. We also determined whether subchronic treatment with pramipexole regulates dopamine transporter function, thereby reducing intracellular transport of the active metabolite of MPTP, 1-methyl-4-phenylpyridinium (MPP+). METHODS: Ten 12-month old C57BL/6 mice were treated with MPTP (or saline) twice per day at 20 mg/kg s.c. (4 injections over 48 h). Mice were pretreated for 3 days and during the 2-day MPTP regimen with pramipexole (0.1 mg/kg/day) or saline. Stereological quantification of dopamine neuron number and optical density measurement of dopamine fiber loss were carried out at 1 week after treatment, using immunostaining for dopamine transporter (DAT) and tyrosine hydroxylase (TH). Additional wild-type (WT) and D(3 )receptor knockout (KO) mice were treated for 5 days with pramipexole (0.1 mg/kg/day) or vehicle. The kinetics of [(3)H]MPP+ and [(3)H]DA uptake (V(max )and K(m)) were determined 24 h later; and at 24 h and 14 days dopamine transporter density was measured by quantitative autoradiography. RESULTS: Pramipexole treatment completely antagonized the neurotoxic effects of MPTP, as measured by substantia nigra and ventral tegmental area TH-immunoreactive cell counts. MPTP- induced loss of striatal innervation, as measured by DAT-immunoreactivity, was partially prevented by pramipexole, but not with regard to TH-IR. Pramipexole also reduced DAT- immunoreactivity in non-MPTP treated mice. Subchronic treatment with pramipexole lowered the V(max )for [(3)H]DA and [(3)H]MPP(+ )uptake into striatal synaptosomes of WT mice. Pramipexole treatment lowered V(max )in WT but not D(3 )KO mice; however, D(3 )KO mice had lower V(max )for [(3)H]DA uptake. There was no change in DAT number in WT with pramipexole treatment or D(3 )KO mice at 24 h post-treatment, but there was a reduction in WT-pramipexole treated and not in D(3 )KO mice at 14 days post-treatment. CONCLUSION: These results suggest that protection occurs at clinically suitable doses of pramipexole. Protection could be due to a reduced amount of MPP(+ )taken up into DA terminals via DAT. D(3 )receptor plays an important role in this regulation of transporter uptake and availability

    GPU-based Approaches for Multiobjective Local Search Algorithms. A Case Study: the Flowshop Scheduling Problem

    Get PDF
    International audienceMultiobjective local search algorithms are efficient methods to solve complex problems in science and industry. Even if these heuristics allow to significantly reduce the computational time of the solution search space exploration, this latter cost remains exorbitant when very large problem instances are to be solved. As a result, the use of GPU computing has been recently revealed as an efficient way to accelerate the search process. This paper presents a new methodology to design and implement efficiently GPU-based multiobjective local search algorithms. The experimental results show that the approach is promising especially for large problem instances

    Rates and determinants of antibiotics and probiotics prescription to children in Asia-Pacific countries

    Get PDF
    Antibiotic therapy may have important side effects. Guidelines recommend the administration of specific probiotics to reduce the risk of antibiotic-associated diarrhoea (AAD). The rates and determinants of antibiotics and co-prescription of probiotics in children remain poorly known in Asia-Pacific countries, which are very heterogenous in terms of economic development, health care organization and health policies. A survey among general practitioners (GPs) and paediatricians was performed in seven countries of the Asia-Pacific area (Australia, Japan, Indonesia, India, China, Singapore, and South Korea). Physicians completed an online questionnaire that explored their current habits and the determinants for prescribing antibiotics and probiotics. For the 731 physicians who completed the questionnaire (390 paediatricians and 341 GPs), 37% of all consultations for a child led to the prescription of antibiotics (ranging from 17% in Australia to 47% in India). A large majority of physicians (84%) agreed that antibiotics disrupted gut microbiota and considered probiotics an effective intervention to prevent AAD (68%). However, only 33% co-prescribed probiotics with antibiotics (ranging from 13% in Japan to 60% in South Korea). The main reasons for prescribing probiotics were previous episodes of AAD (61%), presence of diarrhoea (55%), prolonged antibiotic treatment (54%) or amoxicillin-clavulanic acid therapy (54%). Although current local guidelines recommend the use of selected probiotics in children receiving antibiotics in Asia-Pacific area, the rates of antibiotics and probiotics prescription significantly vary among countries and are deeply affected by country-related cultural and organisational issues

    A note on q-Euler numbers and polynomials

    Full text link
    The purpose of this paper is to construct q-Euler numbers and polynomials by using p-adic q-integral equations on Zp. Finally, we will give some interesting formulae related to these q-Euler numbers and polynomials.Comment: 6 page

    Asthma and Risk of Non-Respiratory Tract Infection: A Population-Based Case-Control Study

    Get PDF
    OBJECTIVES: Asthmatics have increased risks of airway-related infections. Little is known about whether this is true for non-airway-related serious infections such as Escherichia coli bloodstream infection (BSI). We assessed whether asthma is associated with a risk of developing community-acquired E coli BSI. DESIGN: The study was designed as a population-based retrospective case-control study. SETTING: This population-based study was conducted in Olmsted County, Minnesota. PARTICIPANTS: The study included 259 all eligible community-acquired E coli BSI cases in Olmsted County, MN between 1998 and 2007 and 259 birthday-matched, gender-matched and residency-matched controls. PRIMARY AND SECONDARY OUTCOME MEASURES: Only community-acquired E coli BSI cases as the primary outcome was included. Asthma status as an exposure was ascertained by predetermined criteria. An adjusted OR and 95% CI for the association between asthma and risk of community-acquired E coli BSI was calculated using conditional logistic regression. RESULTS: Of 259 eligible cases, 179 (69%) were women and mean age was 61±22 years. Of the 259 cases 37 (14%) and 16 (6%) of 259 controls had a prior history of asthma (adjusted OR 2.74; 95% CI 1.11 to 6.76; p=0.029). The population attributable risk of asthma for community-acquired E coli BSI was 9%. Although not statistically significant, there was a borderline association between having a history of food allergy and increased risk of community-acquired E coli BSI (6% vs 2%; adjusted OR 3.51; 95% CI 0.94 to 13.11; p=0.062). CONCLUSIONS: Based on the findings of the current population-based, case-control investigation, a history of asthma may be associated with risk of community-acquired E coli BSI. The impact of asthma on risk of microbial infections may go beyond airways

    On the Barnes’ type related to multiple Genocchi polynomials

    Get PDF
    Using fermionic p-adic invariant integral on Z p , we construct the Barnes' type multiple Genocchi numbers and polynomials. From those numbers and polynomials, we derive the twisted Barnes' type multiple Genocchi numbers and polynomials. Moreover, we will find the Barnes' type multiple Genocchi zeta function

    Down syndrome-recent progress and future prospects

    Get PDF
    Down syndrome (DS) is caused by trisomy of chromosome 21 (Hsa21) and is associated with a number of deleterious phenotypes, including learning disability, heart defects, early-onset Alzheimer's disease and childhood leukaemia. Individuals with DS are affected by these phenotypes to a variable extent; understanding the cause of this variation is a key challenge. Here, we review recent research progress in DS, both in patients and relevant animal models. In particular, we highlight exciting advances in therapy to improve cognitive function in people with DS and the significant developments in understanding the gene content of Hsa21. Moreover, we discuss future research directions in light of new technologies. In particular, the use of chromosome engineering to generate new trisomic mouse models and large-scale studies of genotype-phenotype relationships in patients are likely to significantly contribute to the future understanding of DS
    corecore